期刊文献+

急性白血病zo-1基因启动子区甲基化状态研究 被引量:1

Methylation Status of zo-1 Gene Promoter in Acute Leukemia
暂未订购
导出
摘要 本研究探讨健康人和急性白血病(AL)不同时期患者zo-1基因启动子区甲基化状态差异。采用硫化测序特异性PCR(BS-PCR)方法对白血病细胞系、AL患者及健康人骨髓标本进行zo-1基因启动子区甲基化状况检测。结果显示:在健康人骨髓中呈低甲基化状态(1.9%),初治、复发和完全缓解的AL患者骨髓中zo-1基因呈高甲基化状态,甲基化率分别为93.2%、66.9%及16.4%,明显高于健康人,差异均有统计学意义(p<0.05)。结论:与健康人相比,急性白血病患者骨髓细胞zo-1基因呈高甲基化状态,且AL不同时期的患者中zo-1基因都发生了不同程度的甲基化改变,对zo-1基因甲基化状态的分析有助于监测AL患者疾病的进展。 This study was purposed to investigate the difference of zo-1 gene promoter methylation between healthy individuals and acute leukemia patients. BS-PCR method was used to detect the status of zo-1 gene methylation in healthy individuals, acute leukemia patients and leukemic cell line NB4 cells. The results showed that zo-1 gene was hypomethylated in bone marrow samples from healthy individuals( 1.9% ). In newly diagnosed AL and relapsed patients, the rate of zo-1 gene methylation was 93.2% and 66.9% respectively, while it was 16.4% in AL patients in complete remission, which was much higher than that in healthy individuals. There was significant difference between them. It is concluded that as compared with healthy individuals, zo-1 gene in acute leukemia patients is hypermethylated and with different degrees in various phases of leukemia. Analysis of zo-1 gene methylation status may be useful to monitor the development of acute leukemia.
出处 《中国实验血液学杂志》 CAS CSCD 2010年第4期863-865,共3页 Journal of Experimental Hematology
基金 国家自然科学基金资助项目(编号30670898) 973国家重点基础研究专项经费资助项目(编号2005CB522400) 首发基金项目(编号2007-2040)
关键词 ZO-1基因 急性白血病 DNA甲基化 zo-1 gene acute leukemia DNA methylation
  • 相关文献

参考文献3

二级参考文献4

共引文献89

同被引文献73

  • 1Dellett M, O'Hagan KA, Colyer HA, Mills KI. Identification of gene networks associated with acute myeloid leukemia by comparative molecular methylation and expression profiling. Biomark Cancer 2010; 2: 43-55.
  • 2Singh R, Cadeddu RP, Frobel J, Wilk CM, Bruns I, Zerbini LF, et al. The non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway. Apoptosis 2011; 16(9): 889-901.
  • 3Khasawneh MK, Abdel-Wahab O. Recent discoveries in molecular characterization of acute myeloid leukemia. Curr Hematol Malig Rep 2014; 9(2): 93-9.
  • 4Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013, CA Cancer J Clin 2013; 63(1): 11-30.
  • 5常乃柏.急性髓系白血病DNA甲基化及治疗进展.中华临床医师杂志2013;12:5504-6.
  • 6Kozu T, Fukuyama T, Yamami T, Akagi K ,Kaneko Y. MYND- less splice variants of AML 1-MTG8 (RUNX 1-CBFA2T 1) areexpressed in leukemia with t(8;21). Genes Chromosomes Cancer 2005; 43(1): 45-53.
  • 7Wang Q, Sun R, Wu L, Huang J, Wang P, Yuan H, et al. Identification and characterization of an alternative splice variant of Mpl with a high affinity for TPO and its activation of ERK1/2 signaling, hat J Biochem Cell Bio12013; 45(12): 2852-63.
  • 8Sorrell A, Espenschied C, Wang W, Weitzel J, Chu S, Parker P, et al. Hereditary leukemia due to rare RUNXlc splice variant (L472X) presents with eczematous phenotype. Int J Clin Med 2012; 3(7): doi: 10.4236/ijcm.2012.37110.
  • 9Schnittger S, Kohl TM, Haferlach T, Kern W, Hiddemann W, Spiekermann K, et al. KIT-D816 mutations in AML1-ETO- positive AML are associated with impaired event-free and overall survival. Blood 2006; 107(5): 1791-9.
  • 10Gonzalez M, Barragan E, Bolufer P, Chillon C, Colomer D, Borstein R, et al. Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: A study of the PETHEMA group. Br J Haemato12001; 114(1): 99-103.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部